Medical Ikkou Group Co (3353.T) Stock Price
Medical Ikkou Group Co Price
Over the last 19 years Medical Ikkou Group Co grew revenue by 8.3% annually, reaching 48.39 B JPY. Earnings per share have grown at 6.7% per year over the last 19 years. For Medical Ikkou Group Co, the net margin of 2.3% is broadly stable versus 2.6% a few years ago. At today's price the dividend yield works out to roughly 3.57%. The payout ratio is around 33% of earnings. The dividend has grown at 14.6% per year over the past 19 years. The stock trades about 7% above its 52-week low.
Medical Ikkou Group Co stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Medical Ikkou Group Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medical Ikkou Group Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medical Ikkou Group Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Medical Ikkou Group Co Price |
|---|---|
| 9/11/2026 | 2,798.00 JPY |
| 9/10/2026 | 2,804.00 JPY |
| 9/9/2026 | 2,806.00 JPY |
| 9/8/2026 | 2,803.00 JPY |
| 9/7/2026 | 2,810.00 JPY |
| 9/4/2026 | 2,812.00 JPY |
| 9/3/2026 | 2,805.00 JPY |
| 9/2/2026 | 2,811.00 JPY |
| 9/1/2026 | 2,814.00 JPY |
| 8/31/2026 | 2,814.00 JPY |
| 8/28/2026 | 2,812.00 JPY |
| 8/27/2026 | 2,881.00 JPY |
| 8/26/2026 | 2,900.00 JPY |
| 8/25/2026 | 2,895.00 JPY |
| 8/24/2026 | 2,895.00 JPY |
| 8/21/2026 | 2,880.00 JPY |
| 8/20/2026 | 2,877.00 JPY |
| 8/19/2026 | 2,858.00 JPY |
| 8/18/2026 | 2,868.00 JPY |
| 8/17/2026 | 2,867.00 JPY |
| 8/14/2026 | 2,874.00 JPY |
| 8/13/2026 | 2,877.00 JPY |
| 8/12/2026 | 2,896.00 JPY |
| 8/10/2026 | 2,836.00 JPY |
| 8/7/2026 | 2,854.00 JPY |
| 8/6/2026 | 2,836.00 JPY |
| 8/5/2026 | 2,866.00 JPY |
| 8/4/2026 | 2,821.00 JPY |
| 8/3/2026 | 2,843.00 JPY |
| 7/31/2026 | 2,855.00 JPY |
Medical Ikkou Group Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB JPY |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB JPY |
| EBITB JPY |
| EBIT MARGIN% |
| NET INCOMEB JPY |
| NET INCOME GROWTH% |
| DIVIDENDDIV.JPY |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.19 | 17.97 | 19.58 | 20.58 | 22.87 | 26.39 | 29.31 | 29.49 | 30.92 | 31.22 | 32.04 | 31.60 | 33.60 | 33.90 | 39.90 | 48.39 |
| 6.95 | 4.59 | 8.92 | 5.10 | 11.17 | 15.36 | 11.06 | 0.63 | 4.84 | 0.99 | 2.63 | -1.37 | 6.31 | 0.90 | 17.71 | 21.28 |
| 10.88 | 10.79 | 11.64 | 10.96 | 11.10 | 11.24 | 10.93 | 11.09 | 11.31 | 10.46 | 10.73 | 10.14 | 10.76 | 9.39 | 11.41 | 11.87 |
| 1.87 | 1.94 | 2.28 | 2.25 | 2.54 | 2.97 | 3.20 | 3.27 | 3.50 | 3.27 | 3.44 | 3.20 | 3.61 | 3.18 | 4.55 | 5.74 |
| 0.98 | 0.99 | 1.21 | 1.10 | 1.26 | 1.27 | 1.43 | 1.20 | 1.41 | 1.04 | 1.20 | 1.03 | 1.28 | 0.94 | 1.56 | 1.69 |
| 5.68 | 5.50 | 6.20 | 5.35 | 5.50 | 4.81 | 4.87 | 4.07 | 4.54 | 3.34 | 3.76 | 3.25 | 3.80 | 2.76 | 3.91 | 3.50 |
| 0.46 | 0.51 | 0.62 | 0.79 | 0.69 | 0.80 | 0.91 | 0.96 | 1.24 | 0.71 | 0.80 | 0.83 | 0.85 | 0.76 | 1.04 | 1.13 |
| 38.91 | 12.25 | 21.64 | 26.76 | -13.27 | 16.18 | 14.18 | 5.05 | 29.50 | -42.57 | 12.66 | 4.12 | 2.16 | -10.92 | 36.89 | 9.05 |
| 25.00 | 9.50 | 40.00 | 50.00 | 50.00 | 35.00 | 36.00 | 40.00 | 40.00 | 40.00 | 42.50 | 40.00 | 40.00 | 40.00 | 50.00 | 100.00 |
| 25.00 | -62.00 | 321.05 | 25.00 | – | -30.00 | 2.86 | 11.11 | – | – | 6.25 | -5.88 | – | – | 25.00 | 100.00 |
| 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.92 | 3.83 | 3.83 | 3.83 | 3.83 | 3.81 | 3.77 | 3.76 | 3.76 | 3.76 | 3.76 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Medical Ikkou Group Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medical Ikkou Group Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medical Ikkou Group Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Medical Ikkou Group Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medical Ikkou Group Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Medical Ikkou Group Co stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co business model & stock analysis
Medical Ikkou Group Co Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Medical Ikkou Group Co historical P/E ratio, EBIT multiple, and P/S ratio
Medical Ikkou Group Co annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Medical Ikkou Group Co shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co stock splits
Medical Ikkou Group Co Dividend History
22 years of dividend payments · 2 consecutive increases
Medical Ikkou Group Co dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Medical Ikkou Group Co shareholder structure
| % | Name |
|---|---|
0.00266% |
Medical Ikkou Group Co Beneficial Ownership Filings (SEC 13D/G)
Medical Ikkou Group Co Executives and Management Board
18 members · avg. age 59 · 6 % women
Management
Mr. Toshihisa Minamino (66)
President, Group Chief Executive Officer, President of Subsidiary, Representative Director · since 2005
Mr. Kiyoshi Hattori (61)
President of Subsidiary, Director · since 2018
Mr. Toshiharu Sakurai (68)
Senior Managing Director, President of Subsidiary, Representative Director · since 2006
Mr. Kunihiko Toyama (56)
Managing Director, Director of Finance & IR
Mr. Takamitsu Tachibana (51)
Senior Executive Officer, General Affairs and Human Resources
Mr. Yoshiyuki Adachi (63)
Senior Executive Officer · since 2006
Board of Directors
Mr. Yutaka Horie (63)
Independent Director
Ms. Keiko Horino (40)
Independent Director
Mr. Shigehiro Kuwahara
Independent Director
Frequently asked questions about Medical Ikkou Group Co
Converted at the current exchange rate, the Medical Ikkou Group Co share trades at 15.71 EUR (2,798.00 JPY).
No history available for Medical Ikkou Group Co.
The revenue cannot currently be calculated for Medical Ikkou Group Co.
The profit cannot currently be calculated for Medical Ikkou Group Co.
The P/E ratio cannot be calculated for Medical Ikkou Group Co at the moment.
The P/S cannot be calculated for Medical Ikkou Group Co currently.
The Eulerpool Quality Score for Medical Ikkou Group Co is 6/10.
The ISIN of Medical Ikkou Group Co is JP3921040006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medical Ikkou Group Co is 3353.T. The ticker symbol is used to trade Medical Ikkou Group Co shares on the stock exchange.
Over the past 12 months, Medical Ikkou Group Co paid a dividend of 100.00 JPY . This corresponds to a dividend yield of about 3.57 %. For the coming 12 months, Medical Ikkou Group Co is expected to pay a dividend of 50.00 JPY.
The current dividend yield of Medical Ikkou Group Co is 3.57 %.
Medical Ikkou Group Co pays a dividend, distributed in the months of , , , .
Medical Ikkou Group Co paid dividends every year for the past 21 years.
For the upcoming 12 months, dividends amounting to 50.00 JPY are expected. This corresponds to a dividend yield of 1.79 %.
Medical Ikkou Group Co is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Medical Ikkou Group Co from amounting to 60 JPY, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Medical Ikkou Group Co distributed 40 JPY as dividends.
The dividends of Medical Ikkou Group Co are distributed in JPY.
Medical Ikkou Group Co stock
Medical Ikkou Group Co Peer Group
Medical Ikkou Group Co FIGI
All fundamentals and in-depth analysis of Medical Ikkou Group Co
Our stock analysis for Medical Ikkou Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medical Ikkou Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.